You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-DNA Ligase IV antibody (ab26039)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-DNA Ligase IV antibody
See all DNA Ligase IV products (3) ...

Description

Rabbit polyclonal to DNA Ligase IV

Tested applications

IHC-P, IP, WBmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat, Chicken, Dog

Immunogen

A region within a synthetic peptide: IADIEHIEKD MKHQSFYIET KLDGERMQMH KDGDVYKYFS RNGYNYTDQF, corresponding to internal sequence amino acids 253-302 of DNA Ligase IV

IADIEHIEKD MKHQSFYIET KLDGERMQMH KDGDVYKYFS RNGYNYTDQF

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: 2% Sucrose, PBS

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - DNA Ligase IV antibody (ab26039)Western blot - DNA Ligase IV antibody (ab26039) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - DNA Ligase IV antibody (ab26039)Immunohistochemistry (Paraffin-embedded sections) - DNA Ligase IV antibody (ab26039) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab26039 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

IHC-P: Use at a concentration of 4.0 - 8.0 µg/ml.
IP: Use at an assay dependent dilution (PMID 18451142).
WB: Use at a concentration of 1.25 µg/ml. Predicted molecular weight: 109 kDa.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Efficiently joins single-strand breaks in a double-stranded polydeoxynucleotide in an ATP-dependent reaction. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The LIG4-XRCC4 complex is responsible for the NHEJ ligation step, and XRCC4 enhances the joining activity of LIG4. Binding of the LIG4-XRCC4 complex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends.

Tissue specificity

Testis, thymus, prostate and heart.

Involvement in disease

Defects in LIG4 are the cause of LIG4 syndrome (LIG4S) [MIM:606593]. This disease is characterized by immunodeficiency and developmental and growth delay. Patients display unusual facial features, microcephaly, growth and/or developmental delay, pancytopenia, and various skin abnormalities.
Defects in LIG4 are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. Individuals affected by RS-SCID show defects in the DNA repair machinery necessary for coding joint formation and the completion of V(D)J recombination. A subset of cells from such patients show increased radiosensitivity.

Sequence similarities

Belongs to the ATP-dependent DNA ligase family.
Contains 2 BRCT domains.

Cellular localization

Nucleus.

Target information above from: UniProt accessionP49917 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • DNA ligase IV ATP dependent antibody
  • DNA ligase IV ATP dependent antibody
  • DNA joinase antibody
  • DNA joinase antibody
  • DNA ligase 4 antibody
  • DNA ligase IV antibody
  • DNA repair enzyme antibody
  • DNA repair enzyme antibody
  • DNLI4_HUMAN antibody
  • LIG 4 antibody
  • LIG4 antibody
  • LIG4 antibody
  • Ligase IV antibody
  • Ligase IV antibody
  • Ligase IV DNA ATP dependent antibody
  • Polydeoxyribonucleotide synthase [ATP] 4 antibody
  • Polydeoxyribonucleotide synthase 4 antibody
  • Polydeoxyribonucleotide synthase antibody
  • Polydeoxyribonucleotide synthase antibody
  • Polynucleotide ligase antibody
  • Polynucleotide ligase antibody
  • Sealase antibody
  • Sealase antibody
see all

Anti-DNA Ligase IV antibody images:

  Western blot - DNA Ligase IV antibody (ab26039)

Western blot - DNA Ligase IV antibody (ab26039)

Anti-DNA Ligase IV antibody (ab26039) at 1.25 µg/ml + HepG2 cell lysate

Predicted band size : 109 kDa

  Immunohistochemistry (Paraffin-embedded sections) - DNA Ligase IV antibody (ab26039)

Immunohistochemistry (Paraffin-embedded sections) - DNA Ligase IV antibody (ab26039)

ab26039 at a concentration of 6.0 µg/ml staining human DNA Ligase IV by Immunohistochemistry in paraffin embedded pancreas tissue. Cells with positive label (as indicated by the arrows) are epithelial cells of the pancreatic acinus. Magnification 400X.

References for Anti-DNA Ligase IV antibody (ab26039)

This product has been referenced in:

See all 3 publications for this product

Publishing research using ab26039? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"